Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

Wallace Brownlee, Dennis Bourdette, Simon Broadley, Joep Killestein, Olga Ciccarelli

Research output: Contribution to journalReview articlepeer-review

126 Scopus citations

Abstract

The emergence of novel coronavirus 2019 (COVID-19)1 and the subsequent pandemic present a unique challenge to neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD).

Original languageEnglish (US)
Pages (from-to)949-952
Number of pages4
JournalNeurology
Volume94
Issue number22
DOIs
StatePublished - Jun 2 2020
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic'. Together they form a unique fingerprint.

Cite this